LPL Financial’s Cogent Biosciences COGT Stock Holding History

LPL Financial’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.43M	Buy	88,535 +14,380	+19%	+$503K	﹤0.01%	3162
2026 Q1	$2.85M	Sell	74,155 -50,083	-40%	-$1.85M	﹤0.01%	3170
2025 Q4	$4.41M	Buy	124,238 +74,036	+147%	+$2.08M	﹤0.01%	2640
2025 Q3	$721K	Buy	50,202 +31,199	+164%	+$370K	﹤0.01%	4318
2025 Q2	$136K	Hold	19,003	–	–	﹤0.01%	5194
2025 Q1	$114K	Buy	+19,003	New	+$149K	﹤0.01%	5010
2023 Q1	–	Sell	-14,774	Closed	-$171K	–	4501
2022 Q4	$171K	Sell	14,774 -1,500	-9%	-$18.6K	﹤0.01%	4030
2022 Q3	$243K	Buy	+16,274	New	+$223K	﹤0.01%	3764
2021 Q3	–	Sell	-15,000	Closed	-$122K	–	4340
2021 Q2	$122K	Buy	15,000 +4,000	+36%	+$33.8K	﹤0.01%	4022
2021 Q1	$97K	Buy	+11,000	New	+$106K	﹤0.01%	3931

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LPL Financial's COGT Position: Q2 2026 in Review

LPL Financial increased its Cogent Biosciences (COGT) stake by 19% in Q2 2026, buying an estimated $503K and bringing the position to 88,535 shares worth $3.43M. The position accounts for ﹤0.01% of the portfolio, ranked #3162.

LPL Financial first reported a position in COGT in Q1 2021 and has held it in 10 quarters since. The position peaked at $4.41M in Q4 2025. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

LPL Financial held 88,535 shares of Cogent Biosciences worth $3.43M as of Q2 2026.
LPL Financial bought 14,380 Cogent Biosciences shares in Q2 2026, an estimated $503K.
Cogent Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3162 holding.
LPL Financial first reported a position in Cogent Biosciences in Q1 2021 and has held it in 10 quarters since.
LPL Financial's Cogent Biosciences position peaked at $4.41M in Q4 2025.
323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.